Additionally, although it is well known that patients with MODY2 yield cardio-protective lipid profiles compared to T1DM and T2DM patients [31, 32], there were still 4% of GCK-MODY patients reporting with macrovascular disease in an adult GCK-MODY cohort [9]. This evidence concerns the gene GCK and maturity-onset diabetes of the young type 2.